FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

4915611000001104: Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
155661000001116 Anadin Extra tablets (GlaxoSmithKline Consumer Healthcare UK Ltd) 16 tablet 2 x 8 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
155671000001114 Anadin Extra tablets (GlaxoSmithKline Consumer Healthcare UK Ltd) 16 tablet 2 x 8 tablets (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1633221000001111 Anadin Extra tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1633241000001118 Anadin Extra tablets (GlaxoSmithKline Consumer Healthcare) 16 tablet 2 x 8 tablets (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2890221000001119 Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2890241000001112 Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
26909901000001117 Anadin Extra tablets (Wyeth Consumer Healthcare) 16 tablet (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
26910001000001111 Anadin Extra tablets (Wyeth Consumer Healthcare) 16 tablet en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
55265801000001115 Anadin Extra tablets (Wyeth Consumer Healthcare) 16 tablet 2 x 8 tablets en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
60655001000001114 Anadin Extra tablets (Pfizer Ltd) 16 tablet 2 x 8 tablets en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
66121601000001112 Anadin Extra tablets (Pfizer Consumer Healthcare Ltd) 16 tablet 2 x 8 tablets en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Is a Generic Anadin Extra tablets 16 tablet true Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Is pack of Anadin Extra tablets (Haleon UK Ltd) false Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Has active ingredient Caffeine false Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Has active ingredient Aspirin false Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Legal category General sales list true Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Has AMP Anadin Extra tablets (Haleon UK Ltd) true Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Has specific active ingredient Caffeine true Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Has specific active ingredient Aspirin true Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Anadin Extra tablets (Haleon UK Ltd) 16 tablet 2 x 8 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start